Dow Down 0.32% Nasdaq Down 0.62%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
6.85 Down 1.60(18.93%) Apr 29, 4:00PM EDT
|After Hours : 6.85 0.00 (0.00%) Apr 29, 4:55PM EDT
Prev Close:8.45
Open:7.07
Bid:6.83 x 1000
Ask:7.08 x 100
1y Target Est:12.61
Beta:2.03617
Earnings Date:Jul 29 - Aug 2 (Est.)
Day's Range:6.59 - 7.25
52wk Range:6.59 - 19.43
Volume:5,302,751
Avg Vol (3m):1,051,530
Market Cap:596.37M
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNDown 18.93%596.37M
SGENDown 4.85%4.97B
PFEDown 0.61%202.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-1.50
Quarterly EPS Est (Jun-16) :-0.38
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback